Cite
HARVARD Citation
Heskin, J. et al. (2022). Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management. Lancet. 399 (10319), pp. 21-22. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Heskin, J. et al. (2022). Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management. Lancet. 399 (10319), pp. 21-22. [Online].